AVICHM(SH:600765)2023-10-29 16:00Financial Performance - The company's operating revenue for Q3 2023 was approximately ¥2.46 billion, a decrease of 6.71% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2023 was approximately ¥250.14 million, down 29.61% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥244.85 million, a decrease of 30.28% compared to the same period last year[3]. - The company reported a basic earnings per share of ¥0.17 for Q3 2023, a decrease of 29.17% compared to the same period last year[4]. - The weighted average return on net assets was 2.27% for Q3 2023, a decrease of 1.3 percentage points year-on-year[4]. - Total operating revenue for the first three quarters of 2023 reached ¥7,967,849,138.36, an increase of 3.24% compared to ¥7,718,339,155.80 in the same period of 2022[17]. - Net profit for the third quarter of 2023 was ¥1,085,115,496.14, up from ¥1,016,028,811.66 in the same quarter of 2022, representing a growth of 6.79%[20]. - Basic earnings per share for the third quarter of 2023 were ¥0.70, compared to ¥0.62 in the same quarter of 2022, indicating an increase of 12.90%[23]. - The total profit for the third quarter of 2023 was ¥1,271,451,595.79, compared to ¥1,219,905,748.53 in the same quarter of 2022, showing an increase of 4.23%[21]. - The total comprehensive income for the third quarter of 2023 was ¥1,084,176,298.26, compared to ¥1,016,028,811.66 in the same quarter of 2022, reflecting an increase of 6.69%[23]. Assets and Liabilities - The total assets at the end of Q3 2023 were approximately ¥24.68 billion, an increase of 17.11% compared to the end of the previous year[4]. - Current assets totaled RMB 17.65 billion, up from RMB 16.06 billion at the end of 2022, indicating a growth of about 9.9%[14]. - Total liabilities amounted to RMB 12.72 billion, up from RMB 10.29 billion, reflecting an increase of approximately 23.6%[16]. - The company's equity attributable to shareholders reached RMB 11.20 billion, compared to RMB 10.39 billion, showing a growth of approximately 7.8%[16]. - Accounts receivable increased significantly to RMB 6.89 billion, compared to RMB 3.83 billion in the previous year, marking an increase of around 79.5%[14]. - Inventory rose to RMB 3.76 billion from RMB 3.32 billion, which is an increase of about 13.4%[14]. - Short-term borrowings surged to RMB 801.56 million from RMB 272.05 million, indicating an increase of about 194.5%[15]. - The company reported a significant increase in accounts payable, which rose to RMB 5.67 billion from RMB 2.76 billion, reflecting an increase of approximately 105.0%[15]. Cash Flow and Expenses - The company’s cash flow from operating activities was negative at approximately -¥459.21 million for the year-to-date period[4]. - Cash flow from operating activities for the first three quarters of 2023 was ¥5,439,293,246.28, an increase from ¥5,022,628,831.85 in 2022, reflecting a growth of 8.29%[24]. - Net cash flow from operating activities was -459,205,833.99, compared to -307,849,158.61 in the previous year, indicating a decline of approximately 49%[25]. - Total cash outflow from investing activities was 958,504,201.07, up from 611,194,774.54, representing an increase of about 57%[25]. - Cash inflow from financing activities totaled 2,312,423,990.55, compared to 573,417,291.18 in the previous year, marking a significant increase of approximately 303%[25]. - Cash paid for employee benefits increased to 973,665,481.80 from 861,620,988.04, showing a rise of approximately 13%[25]. - Cash paid for taxes rose significantly to 570,034,736.31 from 298,100,813.13, indicating an increase of about 91%[25]. - Cash paid for the acquisition of fixed assets and intangible assets was 681,224,592.49, up from 532,829,826.33, representing an increase of about 28%[25]. Research and Development - The company's R&D expenses for Q3 2023 increased by 170.38%, totaling approximately ¥546 million for the first three quarters, with a significant increase of ¥127 million in Q3 alone[7]. - Research and development expenses surged to ¥545,693,729.53 in 2023, compared to ¥212,678,532.56 in 2022, marking an increase of 156.80%[19]. Social Responsibility - The company was awarded the "Best Practice Case" for its contribution to rural revitalization, highlighting its commitment to social responsibility[12].